Programa de Pós-Graduação em Ciências Farmacêuticas-Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
Laboratório de Pesquisa em Resistência Bacteriana (LABRESIS)-Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.
Microbiol Spectr. 2023 Feb 14;11(1):e0437522. doi: 10.1128/spectrum.04375-22. Epub 2023 Jan 25.
Antimicrobial susceptibility testing (AST) that can provide faster results is necessary. The MALDI Biotyper antibiotic susceptibility test rapid assay (MBT-ASTRA) can provide early AST results but still needs to be simplified in order to facilitate its execution by microbiology laboratories. The aim of this study was to evaluate an adaptation of MBT-ASTRA. Isolates of were tested for meropenem susceptibility by MBT-ASTRA using a solution prepared from meropenem disks and performing a manual spectrum analysis. The relative growth (RG) was calculated for each isolate, and a cutoff value was established to determine the susceptibility profile of the isolates. Results of the adapted method were compared with the standard susceptibility method (broth microdilution). An adapted method of MBT-ASTRA was developed. The RG cutoff values for meropenem were ≤0.1510 for susceptibility and >0.6272 for resistance, presenting 95.65% categorical agreement, with 2.9% (2/69) minor discrepancy and 3.23% (1/31) very major discrepancy. MBT-ASTRA can be used to provide rapid AST results with a simpler and more accessible protocol, especially regarding spectrum analysis. The simplification of the MBT-ASTRA technique, especially in spectrum analysis, can considerably allow more laboratories to rapidly determine antimicrobial susceptibility profiles.
需要进行能够提供更快结果的抗菌药物敏感性测试 (AST)。MALDI Biotyper 抗生素药敏快速检测 (MBT-ASTRA) 可以提供早期 AST 结果,但仍需要简化,以便微生物学实验室能够执行。本研究的目的是评估 MBT-ASTRA 的一种改编方法。使用从美罗培南药敏纸片制备的溶液并进行手动光谱分析,对 进行了 MBT-ASTRA 美罗培南药敏测试。计算每个分离物的相对生长 (RG),并建立一个截止值来确定分离物的药敏谱。改编方法的结果与标准药敏方法(肉汤微量稀释法)进行了比较。开发了一种改良的 MBT-ASTRA 方法。美罗培南的 RG 截止值为≤0.1510 表示敏感,>0.6272 表示耐药,具有 95.65%的分类一致性,2.9%(2/69)的次要差异和 3.23%(1/31)的非常大差异。MBT-ASTRA 可用于提供更简单、更易获取的方案快速 AST 结果,尤其是在光谱分析方面。MBT-ASTRA 技术的简化,特别是在光谱分析方面,可以使更多的实验室能够快速确定抗菌药物敏感性谱。